904
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry

, , , , , , , & show all
Article: 2298352 | Received 08 Jun 2023, Accepted 18 Dec 2023, Published online: 03 Jan 2024

References

  • Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol. 2007;50(19):1822–4. doi:10.1016/j.jacc.2007.07.051.
  • Hghlights of Prescribing Information. Naprosyn (naproxen) tablets. [accessed 2023 Feb 5]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf.
  • Gurbel PA, Bliden KP, Zhu J, Troullos E, Centofanti R, Jarvis S, Venkataraman P, Tantry US. Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium. J Thromb Thrombolysis. 2018;45(1):18–26. doi:10.1007/s11239-017-1593-y.
  • Gurbel PA, Bliden KP, Tantry US. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B2 and agonist-induced platelet aggregation. J Thromb Thrombolysis. 2021;51(2):260–64. doi:10.1007/s11239-020-02334-x.
  • Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US. Evaluation of dose-related effects of aspirin on platelet function: results from the aspirin-induced platelet effect (ASPECT) study. Circulation. 2007;115(25):3156–64. doi:10.1161/CIRCULATIONAHA.106.675587.
  • Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol. 2005;46(9):1705–09. doi:10.1016/j.jacc.2005.05.090.
  • Linnet K. Necessary sample size for method comparison studies based on regression analysis. Clin Chem. 1999;45(6):882–94. doi:10.1093/clinchem/45.6.882.
  • Lücker PW, Wetzelsberger N, Schettler T, Rogalla K. Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet. Methods Find Exp Clin Pharmacol. 1992;14:805–11.
  • Volkers A, Löwenberg M, Braad M, Abeling Y, Gecse K, Berkers N, Montazeri N, D’Haens G. Validation study of novel point-of-care tests for infliximab, adalimumab and C-reactive protein in capillary blood and calprotectin in faeces in an ambulatory inflammatory bowel disease care setting. Diagnostics (Basel). 2023;13:1712. doi:10.3390/diagnostics13101712.
  • Gurbel PA, Bliden KP, Chaudhary R, Tantry US. First in-human experience with inhaled acetylsalicylic acid for immediate platelet inhibition: comparison with chewed and swallowed acetylsalicylic acid. Circulation. 2020;142(13):1305–1307. doi:10.1161/CIRCULATIONAHA.120.047477.
  • Atar D, Sarkar S, Kolev E, Mura C, Brosstad F, Theodorsen L, Westen GI, Stribolt-Halvorsen PE. Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet. Int J Clin Pharmacol Ther. 2022;60(10):430–438. doi:10.5414/CP204271.